
Sign up to save your podcasts
Or
After years of setbacks, the announcement of the first drug to slow the brain's decline in Alzheimer's is being hailed as "momentous". What makes this breakthrough different?
To study the effect of the environment on our health, scientists sometimes have to look to the past. We hear from the author of a study which has uncovered how the worst recession in US history may leave an indelible mark on how well people age.
Claudia Hammond’s guest this week James Gallagher, the BBC's health and science correspondent, looks at a new single-dose treatment for sleeping sickness and claims it could help to eradicate transmission of the disease by 2030 and why monkeypox is being renamed.
Presenter: Claudia Hammond
(Picture: Human brain scan in a neurology clinic. Photo credit: Andrew Brookes/Getty Images.)
4.7
7575 ratings
After years of setbacks, the announcement of the first drug to slow the brain's decline in Alzheimer's is being hailed as "momentous". What makes this breakthrough different?
To study the effect of the environment on our health, scientists sometimes have to look to the past. We hear from the author of a study which has uncovered how the worst recession in US history may leave an indelible mark on how well people age.
Claudia Hammond’s guest this week James Gallagher, the BBC's health and science correspondent, looks at a new single-dose treatment for sleeping sickness and claims it could help to eradicate transmission of the disease by 2030 and why monkeypox is being renamed.
Presenter: Claudia Hammond
(Picture: Human brain scan in a neurology clinic. Photo credit: Andrew Brookes/Getty Images.)
5,421 Listeners
1,812 Listeners
126 Listeners
7,665 Listeners
408 Listeners
111 Listeners
1,739 Listeners
1,075 Listeners
343 Listeners
94 Listeners
971 Listeners
272 Listeners
2,065 Listeners
1,045 Listeners
238 Listeners
355 Listeners
66 Listeners
399 Listeners
477 Listeners
243 Listeners
136 Listeners
4,169 Listeners
708 Listeners
2,972 Listeners
213 Listeners